Ali Elitok
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Acute Myocardial Infarction Research
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
- Nephrology top 10%
Papers in
-
- Cardiovascular Function and Risk Factors 4
- Cardiac electrophysiology and arrhythmias 3
- Cardiovascular Effects of Exercise 2
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Acute Myocardial Infarction Research 2
- Surgery 5
- Co-authors
- Hüseyin Oflaz (19 shared papers)Fahrettin Öz (7 shared papers)Zehra Buğra (9 shared papers)Arif Oğuzhan Çimen (11 shared papers)Aytaç Öncül (9 shared papers)Berrin Umman (9 shared papers)Fehmi Mercanoğlu (8 shared papers)Ahmet Yaşar Çizgici (3 shared papers)
- Journals
- Coronary Artery Disease (2 papers)International journal of cardiac imaging (2 papers)Renal Failure (2 papers)Clinical Transplantation (2 papers)Clinical Journal of the American Society of Nephrology (1 paper)
- Partner nations
- TürkiyeNetherlandsUnited States
In The Last Decade
Ali Elitok
47 papers receiving 769 citations
Peers
Comparison fields: 5 of 75
- Cardiology and Cardiovascular Medicine 313
- Nephrology 38
- Transplantation 10
- Epidemiology 123
- Immunology 74
Countries citing papers authored by Ali Elitok
This map shows the geographic impact of Ali Elitok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Elitok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Elitok more than expected).
Fields of papers citing papers by Ali Elitok
This network shows the impact of papers produced by Ali Elitok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Elitok. The network helps show where Ali Elitok may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Elitok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 99 | |
| 2 | 2009 | 66 | |
| 3 | 2013 | 41 | |
| 4 | 2013 | 37 | |
| 5 | 2008 | 37 | |
| 6 | 2012 | 36 | |
| 7 | 2015 | 32 | |
| 8 | 2008 | 30 | |
| 9 | 2009 | 28 | |
| 10 | 2006 | 26 | |
| 11 | 2017 | 24 | |
| 12 | 2013 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2007 | 18 | |
| 15 | A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease. | 2014 | 18 |
| 16 | 2007 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2009 | 17 | |
| 19 | 2021 | 16 | |
| 20 | 2009 | 14 |
About Ali Elitok
Ali Elitok is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Immunology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 49 papers that have together received 784 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (4 papers), Galectins and Cancer Biology (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Cardiovascular Effects of Exercise (2 papers), Inflammation biomarkers and pathways (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Acute Myocardial Infarction Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (313 citations), Nephrology (38 citations), Transplantation (10 citations), Epidemiology (123 citations) and Immunology (74 citations). Ali Elitok has collaborated with scholars based in Türkiye, Netherlands and United States. Frequent co-authors include Hüseyin Oflaz, Fahrettin Öz, Zehra Buğra, Arif Oğuzhan Çimen, Aytaç Öncül, Berrin Umman, Fehmi Mercanoğlu, Ahmet Yaşar Çizgici, İmran Önür and Fatma Şen. Their work appears in journals such as Coronary Artery Disease, International journal of cardiac imaging, Renal Failure, Clinical Transplantation and Clinical Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.